Naimish Patel Crispr Therapeutics Ag (CRSP) insider trading activity

CRSP Quotes by TradingView

Naimish Patel is Chief Medical Officer of CRISPR Therapeutics AG. Currently has a direct ownership of 6,068 shares of CRSP, which is worth approximately $220,207. The most recent transaction as insider was on May 29, 2025, when has been sold 3,932 shares (Common Shares) at a price of $35.94 per share, resulting in proceeds of $141,316. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 6.07K
n/a 3M change
n/a 12M change
Total Value Held $220,207

Naimish Patel Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 29 2025
SELL
Open market or private sale
$141,316 $35.94 p/Share
3,932 Reduced 39.32%
6,068 Common Shares
May 28 2025
BUY
Exercise of conversion of derivative security
-
10,000 Added 50.0%
10,000 Common Shares
NP

Naimish Patel

Chief Medical Officer
Boston, MA

Track Institutional and Insider Activities on CRSP

Follow CRISPR Therapeutics AG and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRSP shares.

Notify only if

Insider Trading

Get notified when an Crispr Therapeutics Ag insider buys or sells CRSP shares.

Notify only if

News

Receive news related to CRISPR Therapeutics AG

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CRSP